| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Caribou Biosciences, Inc. | Chief Technology Officer | Option to purchase Common Stock | 300K | $807K | $2.69 | Jan 8, 2024 | Direct |
| Homology Medicines, Inc. | Chief Operating Officer | Employee Stock Option (Right to Buy) | 28.2K | $378K | $13.42 | Feb 24, 2022 | Direct |
| Homology Medicines, Inc. | Chief Operating Officer | Restricted Stock Units | 4.8K | $5.52K | $1.15 | Feb 24, 2022 | Direct |
| Homology Medicines, Inc. | Chief Operating Officer | Common Stock | 2.22K | $1.26K | $0.57 | Jan 5, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CRBU | Caribou Biosciences, Inc. | Jan 8, 2024 | 1 | $0 | 4 | Jan 9, 2024 | Chief Technology Officer |
| CRBU | Caribou Biosciences, Inc. | Jan 1, 2024 | 0 | $0 | 3/A | Jan 10, 2024 | Chief Technology Officer |
| CRBU | Caribou Biosciences, Inc. | Jan 1, 2024 | 0 | $0 | 3 | Jan 9, 2024 | Chief Technology Officer |
| FIXX | Homology Medicines, Inc. | Feb 24, 2022 | 2 | $0 | 4 | Feb 28, 2022 | Chief Operating Officer |
| FIXX | Homology Medicines, Inc. | Jan 1, 2022 | 3 | -$5.31K | 4 | Jan 12, 2022 | Chief Operating Officer |
| FIXX | Homology Medicines, Inc. | Sep 3, 2021 | 1 | -$416 | 4 | Sep 8, 2021 | Chief Operating Officer |
| FIXX | Homology Medicines, Inc. | Mar 1, 2021 | 1 | -$69.6K | 4/A | Sep 8, 2021 | Officer |